| Prev Close | 0.00 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 0.00 / 0.00 |
Achillion Pharmaceuticals, Inc. (ACHN)
0.00
NASDAQ
| Exchange | NASDAQ |
| Div & Yield | N.A. (N.A) |
Latest News
4 Biotech Stocks on the Move
These four biotech stocks have been moving on some interesting news and clinical results.
Bears Must Bear With Upward Drift
The upside may look limited here, but it is not easy to fight.
Logic Has Nothing to Do With This Market
There really is no such thing as "bad news" right now because there are buyers regardless.
Nothing for Bears to Get Excited About
Market has been slow but steady with no overtly negative action.
Market Advantage Shifts to the Pessimists
Buyers don't have much staying power.
Virgin America May Finally Be Ready to Leave the Gate (Plus: PE, GE, CPE, ACHN)
We would look to go long VA on a $39 buy-stop using a $34 sell-stop.
Develop Biotech 'Buy-Sell' Strategy
When to take profits is a tricky but important decision.
A Biotech With Enormous Potential
The market seems to be severely discounting DynaVax's chances of approval for its hep-B treatment.
Two Small-Cap Biotechnology Gems
For speculative investors.
Off the Charts
We're establishing a new position in Zillow, and making a number of other adjustments.
A Step in the Right Direction
But the market still has more work to do.
The Trader Daily
The iShares Transportation Average (IYT) is one to watch.
The Trader Daily
Focus on buying the dip for IWM.
The Trader Daily
There's plenty of opportunity despite the low volume.
The Trader Daily
Forget market chatter, just focus on price.
Playing the New Hepatitis C Drugs
There has been huge progress in treating this lethal disease.
The Trader Daily
A bias between neutral and bullish is most appropriate.
The Trader Daily
Corn is still in a horrific bear market.
The Trader Daily
I suggest you add CORN to your screen.
And We're Off!
Here we go. By Bret Jensen The market is slightly up across the board in the first 30 minutes of trading, and the 10-year Treasury yield is approaching 2.65%. Deckers Outdoor (DECK) is nicely up due to an upgrade at Wells Fargo, which now has price ...
Politics Push Stock Plunger
Political squabbling in the U.S. and in Italy has pushed stocks down globally. Achillion Pharma plunges as Apple Beats Coke on branding.
Biotech's Next Big Thing: Fall Trials
Its been a busy summer for biotech, but the coming weeks will heat up with trials from Biodel, Achillon and Coronado, says Adam Feuerstein, Sr. Columnist at TheStreet.